David Collipp, MD
Physical Medicine & Rehabilitation · Flowood, MSNPI 1811080518
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 59.5% of the total.
Across 93 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Merz Pharmaceuticals, LLC$181
- Scilex Pharmaceuticals Inc.$90
- Eisai Inc.$45
- Biohaven Pharmaceuticals, Inc.$39
- IBSA Pharma Inc.$37
- plus $303 from 14 others
What the payments were for
- Food & beverage$1,714100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $1,020 |
| Merz Pharmaceuticals, LLC | 7 | $181 |
| Scilex Pharmaceuticals Inc. | 7 | $90 |
| Eisai Inc. | 3 | $45 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| IBSA Pharma Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Vertex | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Medline Industries LP | 2 | $27 |
| Lundbeck LLC | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Nalu Medical, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Piramal Critical Care | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| MDD US Operations, LLC | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$1,714 in reported general payments places this provider in the 65th percentile of 21 physical medicine & rehabilitation providers in Mississippi.
See all physical medicine & rehabilitation providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ButransBuprenorphine | 13 | $7,018 |
| Gabapentin | 397 | $5,714 |
| Tramadol Hcl ErTramadol Hcl | 31 | $3,350 |
| Tizanidine Hcl | 150 | $1,861 |
| Baclofen | 78 | $1,746 |
| Tramadol Hcl | 126 | $899 |
| Methylprednisolone | 119 | $775 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 17 | $771 |
| Diclofenac Sodium | 23 | $748 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $639 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 23 | $532 |
| Zonisamide | 40 | $416 |
| Methocarbamol | 75 | $365 |
| Pregabalin | 20 | $342 |
| Meloxicam | 92 | $315 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Flowood
- Michael WinkelmanFlowood$2K
- Rahul VohraFlowood$929
- Philip BlountJackson$103K
- Samuel PolkSouthaven$6K
- Parker BellHattiesburg$5K
- Joshua TuckerPascagoula$5K
- Devin WellsOxford$2K
- Barbara BarnardHattiesburg$2K
- Jennifer May VillacortaJackson$1K
- Hyung KimJackson$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.